Skip Header

1 - 25 of 229 results for uniprot:P16234 in Computationally mapped citations

Page of 10 | Next »

to top of page·  

Results Customize

Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects.

Joosten P.H., Toepoel M., Mariman E.C., Van Zoelen E.J.

Nat. Genet. 27:215-217(2001) GAD 132448 GeneRIF 5156 · Mapped (1)
Associated with DEVELOPMENTAL: neural tube defects; GAD 132448 Observational study of gene-disease association. (HuGE Navigator) GeneRIF 5156

Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphisms.

Bruck P., Wassmann B., Lopez E.R., Hoelzer D., Ottmann O.G.

Leuk. Res. 28:1153-1157(2004) GAD 132447 GeneRIF 5156 · Mapped (5)
Not Associated with UNKNOWN: tyrosine kinase inhibitor pharmacokinetics; GAD 132447 Observational study of gene-disease association. (HuGE Navigator) GeneRIF 5156

Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.

Tambur A.R., Pamboukian S., Costanzo M.R., Heroux A.

J. Heart Lung Transplant. 25:690-698(2006) GAD 152474 GeneRIF 5156 · Mapped (47)
Associated with CARDIOVASCULAR: heart transplant complications; GAD 152474 Observational study of gene-disease association. (HuGE Navigator) GeneRIF 5156

Common variants in the GDF5-UQCC region are associated with variation in human height.

Sanna S., Jackson A.U., Nagaraja R., Willer C.J., Chen W.M., Bonnycastle L.L., Shen H., Timpson N., Lettre G., Usala G. et al.

Nat. Genet. 40:198-203(2008) GAD 599277 · Mapped (21)
Associated with DEVELOPMENTAL: height; GAD 599277

Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas.

Ribom D., Andrae J., Frielingsdorf M., Hartman M., Nister M., Smits A.

J. Neurol. Neurosurg. Psychiatr. 72:782-787(2002) GeneRIF 5156 · Mapped (1)
high expression associated with long survival in patients with grade 2 astrocytomas and oligoastrocytomas GeneRIF 5156

Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells.

Andrae J., Molander C., Smits A., Funa K., Nister M.

Biochem. Biophys. Res. Commun. 296:604-611(2002) GeneRIF 5156 · UniProtKB (1) · Mapped (10)
PDGFRA is endogenenously activated in medulloblastoma tumor cell lines GeneRIF 5156

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.

Pardanani A., Ketterling R.P., Brockman S.R., Flynn H.C., Paternoster S.F., Shearer B.M., Reeder T.L., Li C.Y., Cross N.C., Cools J. et al.

Blood 102:3093-3096(2003) GeneRIF 5156 · Mapped (7)
observations suggest that the FIP1L1-PDGFRA rearrangement occurs in an early hematopoietic progenitor and suggests that the molecular pathogenesis for a subset of SMCD patients is similar to that of HES GeneRIF 5156

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.

Cools J., Quentmeier H., Huntly B.J., Marynen P., Griffin J.D., Drexler H.G., Gilliland D.G.

Blood 103:2802-2805(2004) GeneRIF 5156 · Mapped (8)
results indicate that the fusion of FIP1L1 to PDGFRA occurs rarely in leukemia cell lines GeneRIF 5156

Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects.

Zhu H., Wicker N.J., Volcik K., Zhang J., Shaw G.M., Lammer E.J., Suarez L., Canfield M., Finnell R.H.

Mol. Genet. Metab. 81:127-132(2004) GeneRIF 5156 · Mapped (1)
Result from our case-control study demonstrated that the frequencies of haplotypes with low transcription activity were significantly higher in NTD mothers than that observed in control mothers (odds ratio=2.2 95% CI=1.0-4.6). GeneRIF 5156

High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib.

Al-Ali H.K., Heinrich M.C., Lange T., Krahl R., Mueller M., Muller C., Niederwieser D., Druker B.J., Deininger M.W.

Hematol. J. 5:55-60(2004) GeneRIF 5156 · Mapped (25)
results confirm the high frequency of BCR-ABL kinase domain mutations in patients with secondary resistance to imatinib and exclude mutations of the activation loops of KIT PDGFRA and PDGFRB as causes of resistance in patients without ABL mutations GeneRIF 5156

C/EBP is an essential component of PDGFRA transcription in MG-63 cells.

Afink G., Westermark U.K., Lammerts E., Nister M.

Biochem. Biophys. Res. Commun. 315:313-318(2004) GeneRIF 5156 · Mapped (3)
PDGFRa expression is regulated by C-EBP GeneRIF 5156

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.

Wasag B., Debiec-Rychter M., Pauwels P., Stul M., Vranckx H., Oosterom A.V., Hagemeijer A., Sciot R.

Mod. Pathol. 17:889-894(2004) GeneRIF 5156 · Mapped (8)
PDGFRA mutations were found in 7 (25.0%)gastrointestinal stromal tumors (GISTs) carrying either D842 V mutations or exon 18 deletions. GeneRIF 5156

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

Pardanani A., Brockman S.R., Paternoster S.F., Flynn H.C., Ketterling R.P., Lasho T.L., Ho C.L., Li C.Y., Dewald G.W., Tefferi A.

Blood 104:3038-3045(2004) GeneRIF 5156 · Mapped (8)
FIP1L1-PDGFRA is a relatively infrequent but treatment-relevant mutation in primary eosinophilia that is indicative of an underlying systemic mastocytosis. GeneRIF 5156

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.

Subramanian S., West R.B., Corless C.L., Ou W., Rubin B.P., Chu K.M., Leung S.Y., Yuen S.T., Zhu S., Hernandez-Boussard T. et al.

Oncogene 23:7780-7790(2004) GeneRIF 5156 · Mapped (8)
gene expression profiling of 26 gastrointesstinsal stromsal tumors with known KIT and PDGFRA mutational status GeneRIF 5156

Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene.

Sakurai S., Hasegawa T., Sakuma Y., Takazawa Y., Motegi A., Nakajima T., Saito K., Fukayama M., Shimoda T.

Hum. Pathol. 35:1223-1230(2004) GeneRIF 5156 · Mapped (1)
These results suggest that myxoid epithelioid GISTs are a distinct subtype of GISTs that are closely correlated with the PDGFRA gene mutation GeneRIF 5156

A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas.

De Bustos C., Smits A., Stromberg B., Collins V.P., Nister M., Afink G.

J. Med. Genet. 42:31-37(2005) GeneRIF 5156 · Mapped (1)
link between single nucleotide polymorphisms (SNPs) within the PDGFRalpha gene promoter and the occurrence of brain tumours GeneRIF 5156

Novel missense mutations in the tyrosine kinase domain of the platelet-derived growth factor receptor alpha(PDGFRA) gene in childhood acute myeloid leukemia with t(8;21)(q22;q22) or inv(16)(p13q22).

Hiwatari M., Taki T., Tsuchida M., Hanada R., Hongo T., Sako M., Hayashi Y.

Leukemia 19:476-477(2005) GeneRIF 5156 · Mapped (1)
The Receptor PDGF alpha (PDGFRA)is implicated in the pathogenesis of AML and the mechanisms of cytogenetic progression and oncoprotein-driven function may be similar in AML expressing oncogenic forms of PDGFRA. GeneRIF 5156

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.

Debiec-Rychter M., Cools J., Dumez H., Sciot R., Stul M., Mentens N., Vranckx H., Wasag B., Prenen H., Roesel J. et al.

Gastroenterology 128:270-279(2005) GeneRIF 5156 · Mapped (8)
High sensitivity of the imatinib-resistant KIT -T670I and KIT -V654A and of PDGFRA -D842V mutants to PKC412 in gastrointestinal stromal tumors. GeneRIF 5156

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.

Wilczynski S.P., Chen Y.Y., Chen W., Howell S.B., Shively J.E., Alberts D.S.

Hum. Pathol. 36:242-249(2005) GeneRIF 5156 · Mapped (17)
study demonstrates that platelet-derived growth factor receptor alpha and beta and c-kit protein are expressed in a high percentage of epithelial ovarian cancers GeneRIF 5156

Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells.

Nazarova N., Golovko O., Blauer M., Tuohimaa P.

J. Steroid Biochem. Mol. Biol. 94:189-196(2005) GeneRIF 5156 · Mapped (5)
Western blot showed a high amount of PDGFRalpha and beta proteins in primary stromal cells that could not be detected in prostatic cancer cells. GeneRIF 5156

IFNgamma regulates PDGF-receptor alpha expression in macrophages, THP-1 cells, and arterial smooth muscle cells.

Morelli P.I., Martinsson S., Ostergren-Lunden G., Friden V., Moses J., Bondjers G., Krettek A., Lustig F.

Atherosclerosis 184:39-47(2006) GeneRIF 5156 · Mapped (1)
In human ASMCs IFNgamma again stimulated a transient STAT1-binding to the PDGF-Ralpha promoter. GeneRIF 5156

Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity.

Yi E.S., Strong C.R., Piao Z., Perucho M., Weidner N.

Appl. Immunohistochem. Mol. Morphol. 13:157-161(2005) GeneRIF 5156 · Mapped (1)
single example of Gastrointestinal Stromal Tumor with activating mutation and immunoreactivity without CD117 positivity GeneRIF 5156

Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Takazawa Y., Sakurai S., Sakuma Y., Ikeda T., Yamaguchi J., Hashizume Y., Yokoyama S., Motegi A., Fukayama M.

Am. J. Surg. Pathol. 29:755-763(2005) GeneRIF 5156 · Mapped (8)
The point mutations of c-kit and platelet- derived growth factor receptor alpha genes may play a limited role in the tumorigenesis of type 1 neurofibromatosis-associated gastrointestinal stromal tumors. GeneRIF 5156

FIP1L1-PDGFRalpha-positive myeloproliferative disease with hypereosinophilia: clinical characteristics and pathogenetic therapy.

Nemchenko I.S., Khoroshko N.D., Turkina A.G., Sokolova M.A., Kokhno A.V., Semenova E.A., Zakharova A.V.

Ter. Arkh. 77:90-92(2005) GeneRIF 5156 · Mapped (1)
The hypereosinophilic syndrome may result from a novel fusion tyrosine kinase - FIP1L1-PDGFRalpha - that is a consequence of an interstitial chromosomal deletion. GeneRIF 5156

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

Martin J., Poveda A., Llombart-Bosch A., Ramos R., Lopez-Guerrero J.A., Garcia del Muro J., Maurel J., Calabuig S., Gutierrez A., Gonzalez de Sande J.L. et al.

J. Clin. Oncol. 23:6190-6198(2005) GeneRIF 5156 · Mapped (8)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 5156

to top of page·

Page of 10 | Next »